Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
12/2007
12/21/2007WO2007145326A1 Method for determination of inflammatory disease
12/21/2007WO2007145318A1 Sparc-derived cancer rejection antigen peptide and pharmaceutical comprising the same
12/21/2007WO2007145227A1 Hematopoietic stem cell proliferation promoter
12/21/2007WO2007145192A1 Collagen type iv-like immunoreactive peptide
12/21/2007WO2007144893A2 Antibodies blocking fibroblast growth factor receptor activation and methods of use thereof
12/21/2007WO2007144886A2 Virus-like particles for treatment of viral infections
12/21/2007WO2007144772A2 Adjuvant-sparing multi-dose influenza vaccination regimen
12/21/2007WO2007144730A1 Compositions and methods for delivering anti-activated ras antibodies into cells
12/21/2007WO2007144724A1 Pharmaceutical composition for the sublingual administration of vaccines, method for the preparation of the same and uses thereof
12/21/2007WO2007144046A2 Agent for the treatment of malignant diseases
12/21/2007WO2007143934A1 Pharmaceutical composition for the prophylaxis and treatment of hiv infection and its use
12/21/2007WO2007143917A1 T cell epitope peptides of 6b11 ovarian cancer anti-idiotypic antibody
12/21/2007WO2007126655A8 Eggs having increased antibody titer and methods for making same
12/21/2007WO2007120720A3 Uses and compositions for treatment of crohn's disease
12/21/2007WO2007117996A3 Methods for treating conditions associated with masp-2 dependent complement activation
12/21/2007WO2007112079A3 Multivalent immunogen
12/21/2007WO2007107597A3 Immunogenic construct and a method for the prophylactic or therapeutic treatment of aids
12/21/2007WO2007104000A3 Hybrid protein that converts arachidonic acid into prostacyclin
12/21/2007WO2007089871A8 Polypeptide-nucleic acid conjugate for immunoprophylaxis or immunotherapy for neoplastic or infectious disorders
12/21/2007WO2007087851A3 Method for producing epitomers and their uses on carrier microorganisms
12/21/2007WO2007081288A9 Mucosal immunogenic substances comprising a polyinosinic acid - polycytidilic acid based adjuvant
12/21/2007WO2007081287A9 Immunogenic substances comprising a polyinosinic acid - polycytidilic acid based adjuvant
12/21/2007WO2007058860A3 Mrhos as modifiers of the rho pathway and methods of use
12/21/2007WO2007056540A3 Tnf-alpha blocker treatment for enterocolitis associated with immunostimulatory therapeutic antibody therapy
12/21/2007WO2007042261A3 Compositions comprising cross-species-specific antibodies and uses thereof
12/21/2007WO2007033216A3 Methods and compositions for the treatment and diagnosis of diseases characterized by vascular leak, hypotension, or a procoagulant state
12/21/2007WO2006138739A3 Ilt3 binding molecules and uses therefor
12/21/2007WO2006116475A3 Immunostimulatory compositions
12/21/2007WO2006099592A3 Mannose immunogens for hiv-1
12/21/2007WO2006037383A8 Piscirickettsia salmonis antigens and use thereof
12/21/2007WO2005116270A3 Influenza virus vaccine composition and method of use
12/21/2007WO2005044012A3 Method for the decontamination of biological tissue
12/21/2007WO2004071405A3 Lactate dehydrogenase: a target and reagent for diabetes therapy
12/21/2007CA2836760A1 Co-culture lymphoid tissue equivalent (lte) for an artificial immune system (ais)
12/21/2007CA2659676A1 Co-culture lymphoid tissue equivalent (lte) for an artificial immune system (ais)
12/21/2007CA2657989A1 Adjuvant-sparing multi-dose influenza vaccination regimen
12/21/2007CA2657951A1 Agents for promoting the growth of hematopoietic stem cells
12/21/2007CA2657948A1 Denatured collagen peptides and uses thereof
12/21/2007CA2655504A1 Antibodies blocking fibroblast growth factor receptor activation and methods of use thereof
12/21/2007CA2655411A1 Combination therapy employing lymphotoxin beta receptor binding molecules in combination with second agents
12/21/2007CA2655372A1 Il-17 and il-23 antagonists and methods of using the same
12/21/2007CA2655371A1 Methods for regulating complement cascade proteins using astrovirus coat protein and derivatives thereof
12/21/2007CA2655362A1 Compositions and methods for diagnosing and treating cancer
12/21/2007CA2655361A1 Sparc-derived tumor rejection antigenic peptides and medicaments comprising the same
12/21/2007CA2655246A1 Glycosylation engineered antibody therapy
12/21/2007CA2655133A1 Use of alpha-toxin for treating and preventing staphylococcus infections
12/21/2007CA2655080A1 Methods for the treatment of autoimmune disorders using monoclonal antibodies with reduced toxicity
12/21/2007CA2654794A1 Lyophilized formulations of anti-egfr antibodies
12/21/2007CA2654709A1 Neisseria meningitidis lipooligosacchardie vaccine
12/21/2007CA2654706A1 Neisseria meningitidis lipooligosaccharide vaccine
12/21/2007CA2654584A1 Extending survival of cancer patients with elevated levels of egf or tgf-alpha
12/21/2007CA2654563A1 Cytomegalovirus surface protein complex for use in vaccines and as a drug target
12/21/2007CA2654317A1 Single-chain multivalent binding proteins with effector function
12/21/2007CA2654299A1 Methods for manipulating stem cells
12/21/2007CA2654289A1 Peptides that mimic non-human cross-reactive protective epitopes of the group b meningococcal capsular polysaccharide
12/21/2007CA2653387A1 Administration of anti-cd3 antibodies in the treatment of autoimmune diseases
12/21/2007CA2652703A1 Antibodies recognizing a carbohydrate containing epitope on cd-43 and cea expressed on cancer cells and methods using same
12/21/2007CA2651962A1 Anthrax compositions and methods of use and production
12/20/2007US20070293434 Binding polypeptides and methods based thereon
12/20/2007US20070292496 Formulation of liposomal vesicles in aqueous solutions with lachrymal film characteristics
12/20/2007US20070292456 Formulations Containing an Immune Response Modifier
12/20/2007US20070292455 chimeric dna viruses; disrupted open reading frame; for treating or preventing viral infections; immunogens
12/20/2007US20070292454 Therapeutic calcium phosphate particles and methods of manufacture and use
12/20/2007US20070292453 RNA virus vaccines and methods
12/20/2007US20070292452 Vaccine Compositions Which Are Obtained From Streptomyces
12/20/2007US20070292450 Immunogenic Compositions of Staphylococcus Epidermidis Polypeptide Antigens
12/20/2007US20070292449 Long peptides of 22-45 amino acid residues that induce and/or enhance antigen specific immune responses
12/20/2007US20070292448 Preloaded dendritic cell vaccines for treating cancer
12/20/2007US20070292447 Peptide Minotopes of Mycobacterial Mannosylated Lipoglycans and Uses Thereof
12/20/2007US20070292446 Epitope composition for sublingual, buccal or enteric administration prepared by hydrolysis of antigenic structures with chymotrypsin
12/20/2007US20070292445 Delivery system for transdermal immunization
12/20/2007US20070292444 Peptides for treatment and diagnosis of bone diseases
12/20/2007US20070292443 Polypeptides with multifunction
12/20/2007US20070292442 Using cation exchange to separate host cell protein (HCP) form preferential antibody on chromatographic column
12/20/2007US20070292441 Tumor Specific Antibody
12/20/2007US20070292440 CD154 blockade therapy for pancreatic islet tissue transplantation
12/20/2007US20070292439 B cell-related cancers and solid tumors, and diseases or disorders that have an autoimmune and/or inflammatory component, including organ and tissue transplant rejection
12/20/2007US20070292438 Novel Gene Disruptions, Compositions and Methods Relating Thereto
12/20/2007US20070292437 Chlamydia PMP Proteins, Gene Sequences and Uses Thereof
12/20/2007US20070292436 Immunogenic proteoliposomes, and uses thereof
12/20/2007US20070292435 Polypeptide for use in the treatment of tumors, autoimmune, inflammatory and viral diseases; graft vs. host disease
12/20/2007US20070292434 Blocking tetramerization of leptin receptor with anti-fibronectin III domain antibody, inhibiting leptin induced signalling; binding of a compound to non-leptin-binding domains of extracellular part of leptin receptor can block leptin-induced signaling without blocking leptin binding; weight modulation
12/20/2007US20070292433 Compounds and methods for treatment of chemotherapy-induced anemia
12/20/2007US20070292432 Immunoglobulins
12/20/2007US20070292431 4-1Bb Receptors are Expressed on Regulatory T-Cells
12/20/2007US20070292430 PYRROLO[2,3-d]PYRIMIDINE COMPOUNDS
12/20/2007US20070292429 Biocompatible devices, systems, and methods for reducing levels of pro-inflammatory or anti-inflammatory stimulators or mediators in the blood
12/20/2007US20070292428 Antibodies Against Cancer Produced Using Masked Cancer Cells as Immunogen
12/20/2007US20070292427 Substantially pure steroidogenesis inducing peptide and uses thereof
12/20/2007US20070292425 Chlamydia PMP Proteins, Gene Sequences and Uses Thereof
12/20/2007US20070292424 Novel human eosinophil-derived basic protein
12/20/2007US20070292423 Method of Defining the Differentiation Grade of Tumor
12/20/2007US20070292422 Using CD70 specific immunoglobulins to prevent and treat cell proliferative disorders; immunosuppressant
12/20/2007US20070292421 Method for treating preeclampsia
12/20/2007US20070292420 For diagnosing or treating rheumatoid arthritis, osteoarthritis, osteolysis, aseptic loosening of orthopedic implants, lupus, type 2 diabetes, COPD, and renal cell carcinoma
12/20/2007US20070292419 Treatment with anti-erbb2 antibodies
12/20/2007US20070292418 Compositions and methods for immunotherapy
12/20/2007US20070292417 Chimeric allgraft tolerance induction, monitoring and maintenance
12/20/2007US20070292416 De-Immunized Anti-Cd3 Antibody
12/20/2007US20070292415 Compositions and methods for the therapy and diagnosis of breast cancer
1 ... 797 798 799 800 801 802 803 804 805 806 807 808 809 810 811 812 813 814 815 816 817 ... 1823